Evaluation of Kamuvudine-8 in Subjects With Geographic Atrophy

Clinical trial NCT06164587 · COMPLETED

Trial details

NCT number: NCT06164587
Sponsor: Inflammasome Therapeutics
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Geographic Atrophy Age-Related Macular Degeneration

Start date: 2024-04-18
Primary completion: 2026-05-15
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.